课题基金 / 基金详情

Establishment of the analytical system on a fine volume synovial fluid in the human temporomandibular joint

Establishment of the analytical system on a fine volume synovial fluid in the human temporomandibular joint
人颞下颌关节微量滑液分析系统的建立
批准号:
07557127
负责人:
SHIBATA Takanori
金额:
$7.87万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

SHIBATA Takanori的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1) Interleukin 1beta levels in synovial fluid of the TMJ have a positive correlation with OA change. The Stromelysin (MMP3) activity detected was greatly increased in patients with cartilage degradation. These changes may be important markers of early bone deterioration in TMJ_s that are undetectable by radiograph imaging.2) Concomitant increases in the level of cytokines (IL-1 and IL-6) and active forms of MMP_s could be potential catabolic markers for cartilage degradation in the TMJ.3) The PGE_2 level in the TMJ synovial fluid does not specifically reflect the intensity of pain or synovitis, but the detection of high concentrations of C4S and C6S,compared to the amount of HA,is a possible marker of proteoglycan degradation in the TMJ.4) The ratio of concentrations of C4S and C6S in the synovial fluid of the TMJ reflect the proteoglycan metabolism of the joint tissues, particularly of the articular cartilage and synovial tissue. This ratio could be used to diagnose joint diseases and to predict articular cartilage destruction or synovial proliferation due to these diseases.5) Aspiration should be repeated at least 5 times in order to remove high molecular weight substances from synovial fluid. However, when the intraarticular pathology is more complex, adequate removal of high molecular weight substances can not be achieved, even when aspiration is repeated 9 times.6) Our modified direct aspiration technique is both logical and will yield the highest success rate possible when attempting direct aspiration of TMJ synovial fluid.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
E., Kubota: "Synovial Fluid Cytokines and Protenases as Markers of Temporo mandibular Joint Pisease" J.Oral Maxillofac Surg. 56. 192-198 (1998)
E.,久保田:“滑液细胞因子和蛋白酶作为颞下颌关节皮病的标记”J.Oral Maxillofac Surg。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
E. Kubota et al: "Synovial Fluid Cytokines and Proteinases as Markers of Temporomandibular Joint Disease." J. Oral Maxillofac Surg. 56. 192-198 (1998)
E. Kubota 等人:“滑液细胞因子和蛋白酶作为颞下颌关节疾病的标志物。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
E., Kubota.et al: "Interleukin l β and Stromelysin(MMP3)Activity of synovial fluid as Possible Markers of osteoarthritis in the TMJ" J.Oral Maxillofac Surg. 55. (1997)
E.,Kubota.et al:“滑液中白细胞介素 1 β 和基质溶素 (MMP3) 的活性作为 TMJ 中骨关节炎的可能标志物”J.Oral Maxillofac Surg. 55。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
E.Kubota: "Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease"J Oral Maxillofac Surg. 56. 192-198 (1998)
E.Kubota:“滑液细胞因子和蛋白酶作为颞下颌关节疾病的标志物”J Oral Maxillofac Surg。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Catalytic Asymmetric Synthesis of Cage-type Organic Compounds by New Stereo-controlled Approach
    • 批准号:
      23655091
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2011
    • 负责人:
      SHIBATA Takanori
    • 依托单位:
    Synthesis of Chiral and Cyclic pai-Conjugated System Using Cycloaddition
    • 批准号:
      22350046
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.65万
    • 财政年份:
      2010
    • 负责人:
      SHIBATA Takanori
    • 依托单位:
    Construction of New Chiral Skeletons Using by Catalytic Cycloaddition
    • 批准号:
      19350052
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.65万
    • 财政年份:
      2007
    • 负责人:
      SHIBATA Takanori
    • 依托单位:
    A New Approach to the Construction of Carbon Framework Using Metallacumulene Derivatives
    • 批准号:
      16350059
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.51万
    • 财政年份:
      2004
    • 负责人:
      SHIBATA Takanori
    • 依托单位:
    海外基金